Other languages NovoCure Limited

Equities

NVCR

JE00BYSS4X48

Real-time Estimate Cboe BZX Other stock markets 11:29:28 2024-05-02 am EDT			5-day change	1st Jan Change
12.7 ^USD	-0.27%		+3.11%	-15.54%

03:18pm	BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg	MT
02:16pm	BioPharma Credit agrees USD400 million loan for oncology firm Novacure	AN

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg	09:18am
BioPharma Credit agrees USD400 million loan for oncology firm Novacure	08:16am
NovoCure Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	07:01am
NovoCure Limited Announces Results of the Metis Phase 3 Clinical Trial in Brain Metastases from Non-Small Cell Lung Cancer	Apr. 24
NovoCure Says New Data Show TTFields' Potential Therapeutic Effects in Pancreatic Cancer	Apr. 05
Klinische Phase-3-Studie METIS erreicht primären Endpunkt und zeigt eine statistisch signifikante Verlängerung der Zeit bis zur intrakraniellen Progression bei Patient:innen mit Hirnmetastasen von nicht-kleinzelligem Lungenkrebs	Mar. 28
L’essai clinique de phase 3 METIS a atteint son critère principal, démontrant un allongement statistiquement significatif du délai médian jusqu’à la progression intracrânienne chez les patients porteurs de métastases cérébrales consécutives...	Mar. 28
Aktien New York Schluss: Anleger greifen nach Rücksetzer wieder zu	Mar. 27
Zai Lab, Novocure Say TTFields Therapy Delays Intracranial Progression in Non-Small Cell Lung Cancer Brain Metastases Patients	Mar. 27
Sector Update: Health Care Stocks Edge Higher Pre-Bell Wednesday	Mar. 27
Wall Street Set to Open Higher Wednesday as Investors Eye End-of-Week Economic, Inflation Data	Mar. 27
Sector Update: Health Care	Mar. 27
NovoCure Says Trial of Therapy for Brain Metastases From Lung Cancer Met Primary Endpoint; Shares Jump Pre-Bell	Mar. 27
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Board Governor Waller's Speech	Mar. 27
Novocure's lung cancer therapy succeeds in late-stage trial	Mar. 27
Novocure Q4 Net Loss Widens, Revenue Rises	Feb. 22
NovoCure Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22
Sector Update: Health Care Stocks Softer Late Thursday Afternoon	Jan. 18
Top Midday Gainers	Jan. 18
Sector Update: Health Care Stocks Weaker Thursday Afternoon	Jan. 18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NovoCure Limited

Equities

NVCR

JE00BYSS4X48

Other languages

Filters